Patents by Inventor Yongbo FANG

Yongbo FANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230365558
    Abstract: A series of tetrahydroisoquinoline derivatives and the crystal forms thereof. Specifically disclosed are a compound as represented by formula (VII), a crystal form thereof, and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 18, 2021
    Publication date: November 16, 2023
    Inventors: Kevin X CHEN, Zuhao GUO, Yanxin YU, Boyu HU, Jingjing WANG, Zhaoguo CHEN, Cheng XIE, Jian XIONG, Yongbo FANG, Yingtao LIU, Jian LI, Shuhui CHEN
  • Patent number: 10414718
    Abstract: Disclosed in the present disclosure is a Dezocine analog, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: September 17, 2019
    Assignee: Shandong Danhong Pharmaceutical Co., Ltd.
    Inventors: Yang Zhang, Wentao Wu, Zhixiang Li, Guangwen Yang, Yongbo Fang, Tao Zhang, Wei Gu, Shuhui Chen, Fei Wang, Jian Li
  • Publication number: 20190010114
    Abstract: Disclosed in the present disclosure is a Dezocine analogue, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.
    Type: Application
    Filed: January 4, 2017
    Publication date: January 10, 2019
    Inventors: Yang ZHANG, Wentao WU, Zhixiang LI, Guangwen YANG, Yongbo FANG, Tao ZHANG, Wei GU, Shuhui CHEN, Fei WANG, Jian LI